Excerpt
Methods: Since May 1996, consecutive mechanically ventilated patients with ARDS were included [3]. Patients were sedated (flunitrazepam: 1 mg h−1, fentanyl 250 μg h−1). Exclusion criteria were: patients < 18, pregnancy, known sensitivity to muscle relaxants, history of malignant hyperthermia or of seizures, neuromuscular disease, administration of a muscle relaxant during the previous 24 h. Neuromuscular monitoring was quanitified with an accelerograph (TOF-Guard®) at the adductor pollicis muscle. A bolus of 1 mg kg−1 of atracurium was given over 3 min followed by a constant infusion (1 mg kg−1 h−1) for 72 h [3]. TOF count, TOF ratio (T4/T1) ana post-tetanic count stimulation (PTC) were recorded at baseline and 5T min, 60 min, 24, 48, 72 h after bolus. After the cessation of infusion, they were recorded at 5, 10, 15, 20, 30, 60 and 90 min. The time to neuromuscular recovery (T4/T1 ≥70%) was also measured.
Results: Nine patients (seven males, two females, 41-73 years old) were included. APACHE II ranged from 8 to 19. PaO2/FiO2 ratio ranged from 70 to 130 mmHg. The evolution of TOF count is shown in Fig. 1. When TOF count was 0, PTC was recorded from 1 to 7. Recovery from neuromuscular blockade occurred at 37 to 71 min (median value = 55 min) after the cessation of infusion.
Conclusion: This regimen of administration of atracurium provided effective neuromuscular blockade during the infusion and was quickly reversed after the cessation of infusion.